Trial Profile
Intravenous Bisphosphonate in Stress Fracture Treatment
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary) ; Calcium; Vitamin D
- Indications Stress fracture
- Focus Therapeutic Use
- 11 Sep 2019 Status changed from recruiting to discontinued.
- 06 Jul 2018 New trial record